Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
13 May 2024
| N 14:50 | Nirsevimab-alip diffhist +1,936 Alen Antony talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Nirsevimab-alip |aOrAn=a |drugClass=human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody |indicationType=prevention |indication=Respiratory Syncytial Virus (RSV) lower respiratory tract disease for neonates and infants born during or entering their first RSV season and children up to 24 years of age who are vulnerable to severe RSV disease in their second RSV season. |adverseReactions=rashes and injection...") | ||||
| 14:23 | Non-alcoholic fatty liver disease epidemiology and demographics diffhist +1,197 Badgettrg talk contribs (→Overview) | ||||
12 May 2024
|
|
23:08 | Vitamin D 2 changes history +1,636 [Badgettrg (2×)] | |||
|
|
23:08 (cur | prev) +503 Badgettrg talk contribs (→Medical uses) | ||||
|
|
23:00 (cur | prev) +1,133 Badgettrg talk contribs (→Role in depression prevention) | ||||
| 21:59 | Systematic review diffhist +3,699 Badgettrg talk contribs (→Living systematic reviews) | ||||
| 21:06 | Template:KDRG diffhist +47 Kosar Doraghi talk contribs | ||||
|
|
N 21:04 | Somatrogon-ghla 2 changes history +12,691 [Kosar Doraghi (2×)] | |||
|
|
21:04 (cur | prev) +215 Kosar Doraghi talk contribs | ||||
| N |
|
05:30 (cur | prev) +12,476 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.con] |genericName=somatrogon-ghla |aOrAn=a |drugClass=human growth hormone analog |indicationType=treatment |indication=pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone |hasBlackBoxWarning=Yes |adverseReactions=injection site reactions, nasopharyngitis, headache, pyrexia, anemia, cough, v...") | |||
| 20:52 | Chronic renal failure overview diffhist +13,854 Kosar Doraghi talk contribs | ||||
|
|
19:35 | (Upload log) [Kosar Doraghi (8×)] | |||
|
|
19:35 Kosar Doraghi talk contribs uploaded File:IMG 1208.jpeg | ||||
|
|
19:33 Kosar Doraghi talk contribs uploaded File:IMG 1207.jpeg | ||||
|
|
19:32 Kosar Doraghi talk contribs uploaded File:IMG 1204.jpeg | ||||
|
|
19:30 Kosar Doraghi talk contribs uploaded File:IMG 1202.jpeg | ||||
|
|
19:28 Kosar Doraghi talk contribs uploaded File:IMG 1200.jpeg | ||||
|
|
19:24 Kosar Doraghi talk contribs uploaded File:IMG 1214.jpeg | ||||
|
|
05:15 Kosar Doraghi talk contribs uploaded File:IMG 1198.jpeg | ||||
|
|
05:13 Kosar Doraghi talk contribs uploaded File:IMG 1215.jpeg | ||||
11 May 2024
|
|
22:32 | Mirikizumab-mrkz 3 changes history +5,248 [Rithish Nimmagadda (3×)] | |||
|
|
22:32 (cur | prev) +13 Rithish Nimmagadda talk contribs | ||||
|
|
22:31 (cur | prev) 0 Rithish Nimmagadda talk contribs | ||||
|
|
22:26 (cur | prev) +5,235 Rithish Nimmagadda talk contribs | ||||
| N 20:21 | Elfabrio diffhist +3,351 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{VSRN}} |genericName=Pegunigalsidase Alfa-iwxj |drugClass=a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme, is a pegylated recombinant form of human α-galactosidase A |indicationType=treatment |indication=ELFABRIO is an FDA approved drug that is used for treatment of adults with confirmed Fabry disease. |hasBlackBoxWarning=Yes |adverseReactions=Most common adverse reactions (≥15%) are infusion-associated reactio...") | ||||
| N 19:36 | Exxua diffhist +44 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{ }}") | ||||
|
|
19:09 | Facioscapulo-humeral dystrophy 8 changes history +2,898 [Dj (8×)] | |||
|
|
19:09 (cur | prev) +29 Dj talk contribs (→History) | ||||
|
|
18:59 (cur | prev) +191 Dj talk contribs | ||||
|
|
18:45 (cur | prev) +637 Dj talk contribs (→Pathophysiology) | ||||
|
|
18:41 (cur | prev) +138 Dj talk contribs | ||||
|
|
17:59 (cur | prev) +789 Dj talk contribs (→Classification) | ||||
|
|
17:52 (cur | prev) −5 Dj talk contribs | ||||
|
|
17:51 (cur | prev) +363 Dj talk contribs | ||||
|
|
17:43 (cur | prev) +756 Dj talk contribs | ||||
| 12:13 | User:Archana.vajjala diffhist +62 Archana.vajjala talk contribs (→Interests) | ||||
10 May 2024
| 21:12 | Stress ulcer diffhist +1,682 Badgettrg talk contribs (→Drug classes and options available) | ||||
|
|
19:11 | Sotagliflozin 5 changes history +3,623 [Alen Antony (5×)] | |||
|
|
19:11 (cur | prev) +829 Alen Antony talk contribs | ||||
|
|
18:12 (cur | prev) +833 Alen Antony talk contribs | ||||
|
|
17:54 (cur | prev) +545 Alen Antony talk contribs | ||||
|
|
17:46 (cur | prev) +744 Alen Antony talk contribs | ||||
|
|
17:12 (cur | prev) +672 Alen Antony talk contribs | ||||
| 04:13 | Electronic medical record diffhist +119 Badgettrg talk contribs (→Problem lists) | ||||
| 01:58 | User:Archana.vajjala diffhist +2 Archana.vajjala talk contribs | ||||
9 May 2024
|
|
23:59 | Sotagliflozin 2 changes history +1,249 [Alen Antony (2×)] | |||
|
|
23:59 (cur | prev) +19 Alen Antony talk contribs | ||||
|
|
15:17 (cur | prev) +1,230 Alen Antony talk contribs | ||||
| 14:35 | User:Rithish Nimmagadda diffhist +123 Rithish Nimmagadda talk contribs (→Education) | ||||
|
|
N 14:32 | Epcoritamab-bysp 3 changes history +11,459 [Rithish Nimmagadda (3×)] | |||
|
|
14:32 (cur | prev) +11,409 Rithish Nimmagadda talk contribs | ||||
|
|
13:14 (cur | prev) +4 Rithish Nimmagadda talk contribs | ||||
| N |
|
13:10 (cur | prev) +46 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=VSRN }}") | |||
| 10:45 | FUTIBATINIB diffhist −12 Hafiza Amna Qadeer talk contribs | ||||